Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Published: Jan. 25, 2022, 4 p.m.

b'

Editor\'s Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the January 25, 2022 issue.

'